Zbigniew Gaciong

8PUBLICATIONS
27CO-AUTHORS
Haematological tumoursPredictive and prognostic markersPharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

|Aug 28, 2025
Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis.

Kinga Jaskuła, Agata Nawrocka, Piotr Poznański

|Jun 10, 2023
Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial - the AMCOR study.

Piotr Jędrusik, Grzegorz Placha, Zbigniew Gaciong

|Jan 08, 2023
Preference and Adherence to a Fixed-Dose Combination of Bisoprolol-Aspirin and Blood Pressure Control: Results of an Open-Label, Multicentre Study.

Zbigniew Gaciong

|May 05, 2022
A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension.

Ulrike Hostalek-Gottwald, Zbigniew Gaciong

|Aug 02, 2021
Cardiovascular Effects Mediated by HMMR and CD44.

Kinga Jaskuła, Mariusz Sacharczuk, Zbigniew Gaciong

Pageof 2

Frequent Collaborators

2 joint publications

Dominik S Skiba

2 joint publications

Piotr Sobieraj

1 joint publications

Andre Zimerman

1 joint publications

Michelle L O'Donoghue